4.6 Article

A Majority of the Cancer/Testis Antigens Are Intrinsically Disordered Proteins

期刊

JOURNAL OF CELLULAR BIOCHEMISTRY
卷 112, 期 11, 页码 3256-3267

出版社

WILEY
DOI: 10.1002/jcb.23252

关键词

CANCER/TESTIS ANTIGENS; INTRINSICALLY DISORDERED PROTEINS; DOSAGE SENSITIVITY; CANCER

资金

  1. NCI SPORE [2P50CA058236-16]
  2. Patrick C Walsh Prostate Cancer Research Fund
  3. PSOC Grant [NCI U54 CA143803]
  4. NIDDK [P50DK082998]
  5. American Urological Association Foundation

向作者/读者索取更多资源

The cancer/testis antigens (CTAs) are a group of heterogeneous proteins that are typically expressed in the testis but aberrantly expressed in several types of cancer. Although overexpression of CTAs is frequently associated with advanced disease and poorer prognosis, the significance of this correlation is unclear since the functions of the CTAs in the disease process remain poorly understood. Here, employing a bioinformatics approach, we show that a majority of CTAs are intrinsically disordered proteins (IDPs). IDPs are proteins that, under physiological conditions in vitro, lack rigid 3D structures either along their entire length or in localized regions. Despite the lack of structure, most IDPs can transition from disorder to order upon binding to biological targets and often promote highly promiscuous interactions. IDPs play important roles in transcriptional regulation and signaling via regulatory protein networks and are often associated with dosage sensitivity. Consistent with these observations, we find that several CTAs can bind DNA, and their forced expression appears to increase cell growth implying a potential dosage-sensitive function. Furthermore, the CTAs appear to occupy hub positions in protein regulatory networks that typically adopt a scale-free power law distribution. Taken together, our data provide a novel perspective on the CTAs implicating them in processing and transducing information in altered physiological states in a dosage-sensitive manner. Identifying the CTAs that occupy hub positions in protein regulatory networks would allow a better understanding of their functions as well as the development of novel therapeutics to treat cancer. J. Cell. Biochem. 112: 3256-3267, 2011. (C) 2011 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据